Vizsgálati helyszín

NEXT Virginia

Fairfax, Virginia, Egyesült ÁllamokMég nincs intézményhez kötve

58futó vizsgálat
14lezárt vizsgálat
0a helyszín által az elmúlt 60 napban megerősített vizsgálat
–nyelv nincs megadva

A helyszín még egy vizsgálatot sem erősített meg.

Futó vizsgálatok

Toboroz
A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.
NCT07778498· 1/2. fázis· Forrás
Toboroz
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
NCT07730021· 1/2. fázis· Forrás
Toboroz
Study of NXP900 With Lorlatinib in ALK+ Lung Cancer
NCT07784959· 1. fázis· Forrás
Toboroz
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
NCT07383506· 1. fázis· Forrás
Toboroz
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
NCT07524322· 1. fázis· Forrás
Toboroz
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
NCT07529808· 1/2. fázis· Forrás
Toboroz
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
NCT07531095· 1. fázis· Forrás
Toboroz
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
NCT07458347· 1. fázis· Forrás
Toboroz
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
NCT07524855· 1. fázis· Forrás
Toboroz
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
NCT07540572· 1. fázis· Forrás
Toboroz
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
NCT07491497· 1/2. fázis· Forrás
Toboroz
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
NCT07584226· 1/2. fázis· Forrás
Toboroz
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
NCT07287995· 1/2. fázis· Forrás
Toboroz
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
NCT07397338· 1/2. fázis· Forrás
Toboroz
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
NCT07226427· 1. fázis· Forrás
Toboroz
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
NCT07349537· 1. fázis· Forrás
Toboroz
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
NCT07315113· 1. fázis· Forrás
Toboroz
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
NCT07317505· 1. fázis· Forrás
Toboroz
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
NCT07223047· 1/2. fázis· Forrás
Toboroz
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
NCT07300150· 1. fázis· Forrás
Toboroz
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
NCT07227168· 1. fázis· Forrás
Toboroz
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
NCT07111520· 1/2. fázis· Forrás
Toboroz
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
NCT07145255· 1/2. fázis· Forrás
Toboroz
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
NCT07030257· 1/2. fázis· Forrás
Toboroz
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
NCT07094113· 1. fázis· Forrás
Toboroz
A Study of LY4175408 in Participants With Advanced Cancer
NCT07046923· 1. fázis· Forrás
Toboroz
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
NCT07066657· 1. fázis· Forrás
Toboroz
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
NCT06983743· 1. fázis· Forrás
Toboroz
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
NCT06907043· 1/2. fázis· Forrás
Toboroz
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
NCT07029399· 1. fázis· Forrás
Toboroz
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
NCT06810544· 1/2. fázis· Forrás
Toboroz
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
NCT06799065· 1/2. fázis· Forrás
Toboroz
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
NCT06805825· 1. fázis· Forrás
Fut, nem toboroz
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132· 1/2. fázis· Forrás
Toboroz
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
NCT06706076· 1/2. fázis· Forrás
Toboroz
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
NCT06638307· 1. fázis· Forrás
Toboroz
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NCT06586957· 1. fázis· Forrás
Toboroz
Study of XB010 in Subjects With Solid Tumors
NCT06545331· 1. fázis· Forrás
Toboroz
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
NCT06362252· 1/2. fázis· Forrás
Toboroz
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
NCT06303505· 1/2. fázis· Forrás
Fut, nem toboroz
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
NCT06328738· 1. fázis· Forrás
Toboroz
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
NCT06385925· 1/2. fázis· Forrás
Toboroz
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
NCT06179069· 1. fázis· Forrás
Fut, nem toboroz
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
NCT06116786· 1. fázis· Forrás
Toboroz
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
NCT06090266· 1/2. fázis· Forrás
Toboroz
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
NCT06043817· 1/2. fázis· Forrás
Toboroz
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
NCT05652686· 1/2. fázis· Forrás
Toboroz
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
NCT06270706· 1. fázis· Forrás
Toboroz
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
NCT05785741· 1/2. fázis· Forrás
Fut, nem toboroz
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations
NCT05907304· 1. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

Leállították
A Study of PHN-010 in Patients With Advanced Solid Tumors
NCT06457997· 1. fázis· Forrás
Lezárult
Study of INKmune in Patients With mCRPC (CaRe Prostate)
NCT06056791· 1/2. fázis· Forrás
Leállították
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
NCT06052852· 1. fázis· Forrás
Leállították
A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.
NCT05917470· 1/2. fázis· Forrás
Lezárult
PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation
NCT05639751· 1. fázis· Forrás
Leállították
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer
NCT05631574· 1. fázis· Forrás
Lezárult
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
NCT05538572· 1. fázis· Forrás
Visszavonták
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
NCT05191004· 1/2. fázis· Forrás
Visszavonták
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC
NCT05191017· 1/2. fázis· Forrás
Leállították
A Study of the Safety, Tolerability and Effectiveness of EZM0414 (IPN60210) Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma
NCT05121103· 1. fázis· Forrás
Leállították
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
NCT05252390· 1. fázis· Forrás
Lezárult
A Study of PRT2527 in Participants With Advanced Solid Tumors
NCT05159518· 1. fázis· Forrás
Lezárult
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
NCT05002127· 2/3. fázis· Forrás
Leállították
Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer
NCT04982224· 1. fázis· Forrás

Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 7.

Hibát jelzek